|
Volumn 17, Issue 1, 2005, Pages 65-69
|
Medication safety issues in the Emergency Department
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ALTEPLASE;
AMIODARONE;
BENZODIAZEPINE;
BUMETANIDE;
CHLORPROMAZINE;
CONTRAST MEDIUM;
ENALAPRILAT;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
FUROSEMIDE;
HALOPERIDOL;
HEPARIN;
HUMAN INSULIN;
HYDRALAZINE;
INSULIN;
INSULIN ASPART;
LIDOCAINE;
LORAZEPAM;
NESIRITIDE;
NEUROLEPTIC AGENT;
NEUROMUSCULAR BLOCKING AGENT;
OLANZAPINE;
PLASMINOGEN ACTIVATOR;
RETEPLASE;
SEDATIVE AGENT;
SODIUM METABISULFITE;
STREPTOKINASE;
TENECTEPLASE;
THIORIDAZINE;
TISSUE PLASMINOGEN ACTIVATOR;
UNINDEXED DRUG;
ZIPRASIDONE;
AKATHISIA;
ATAXIA;
BEHAVIOR DISORDER;
CATATONIA;
CONGESTIVE HEART FAILURE;
DROWSINESS;
DRUG INFUSION;
DRUG SAFETY;
EMERGENCY;
EMERGENCY WARD;
HEALTH CARE;
HUMAN;
HYPERGLYCEMIA;
HYPOTENSION;
MEDICAL ERROR;
MOTOR DYSFUNCTION;
MUSCLE RIGIDITY;
NURSING;
OCCUPATION;
PARKINSONISM;
QT PROLONGATION;
RESPIRATION DEPRESSION;
REVIEW;
TREMOR;
|
EID: 14644430418
PISSN: 08995885
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccell.2004.09.009 Document Type: Review |
Times cited : (19)
|
References (15)
|